article thumbnail

A Health Consumer Bill of Rights: Assuring Affordability, Access, Autonomy, and Equity

Jane Sarashon

In addition to highlighting the Patient’s Bill of Rights, NABIP’s keynotes and general sessions will speak to similar topics being brainstormed at VIVE this week — including mental health, maternal health, pharmacy and prescription drugs (pricing, PBMs), population health, and Medicare and Medicaid innovations.

ACA 113
article thumbnail

Vendor Notebook: new tools and acquisitions from OptumRx, ScionHealth, others

Healthcare IT News - Telehealth

OptumRx launched Price Edge, a tool that compares pricing for traditional generic drugs to ensure members get the lowest prescription drug prices. It's a new year, and healthcare technology vendors are rolling out their latest innovations, market approvals, acquisitions and staffing shake-ups.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Wasted: $1 of Every $4 Spent on Health Care In America

Health Populi

Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027.

article thumbnail

Hall Render’s Health Provider News – February 25, 2022

Hall Render

Why some Medicaid providers in Colorado aren’t getting paid. Double-booked surgeries lead to $14.6 Whitmer signs bills designed to lower prescription drug prices in Michigan. Missouri Takes Months to Process Medicaid Applications — Longer Than Law Allows. Is this the year NC gets Medicaid expansion?

article thumbnail

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

Adherence is not equal across every state in America, IQVIA Institute learned: for major chronic conditions of hypertension, cholesterol and diabetes, adherence was a low of around 50% among Medicaid enrollees in Arkansas, Iowa and New York; and as high approaching 90% in Minnesota for Medicare Part D enrollees in that state.